Implementation and evaluation of a multi-level mental health promotion intervention for the workplace (MENTUPP): study protocol for a cluster randomised controlled trial.
Depression
Economic evaluation
Implementation
Mental health and wellbeing
Occupational
Organisational interventions
Process evaluation
Self-harm
Suicidal behaviour
Suicide
Workplace health promotion
Workplace-based health interventions
Journal
Trials
ISSN: 1745-6215
Titre abrégé: Trials
Pays: England
ID NLM: 101263253
Informations de publication
Date de publication:
30 Sep 2023
30 Sep 2023
Historique:
received:
10
05
2023
accepted:
25
07
2023
medline:
4
10
2023
pubmed:
1
10
2023
entrez:
30
9
2023
Statut:
epublish
Résumé
Well-organised and managed workplaces can be a source of wellbeing. The construction, healthcare and information and communication technology sectors are characterised by work-related stressors (e.g. high workloads, tight deadlines) which are associated with poorer mental health and wellbeing. The MENTUPP intervention is a flexibly delivered, multi-level approach to supporting small- and medium-sized enterprises (SMEs) in creating mentally healthy workplaces. The online intervention is tailored to each sector and designed to support employees and leaders dealing with mental health difficulties (e.g. stress), clinical level anxiety and depression, and combatting mental health-related stigma. This paper presents the protocol for the cluster randomised controlled trial (cRCT) of the MENTUPP intervention in eight European countries and Australia. Each intervention country will aim to recruit at least two SMEs in each of the three sectors. The design of the cRCT is based on the experiences of a pilot study and guided by a Theory of Change process that describes how the intervention is assumed to work. SMEs will be randomly assigned to the intervention or control conditions. The aim of the cRCT is to assess whether the MENTUPP intervention is effective in improving mental health and wellbeing (primary outcome) and reducing stigma, depression and suicidal behaviour (secondary outcome) in employees. The study will also involve a process and economic evaluation. At present, there is no known multi-level, tailored, flexible and accessible workplace-based intervention for the prevention of non-clinical and clinical symptoms of depression, anxiety and burnout, and the promotion of mental wellbeing. The results of this study will provide a comprehensive overview of the implementation and effectiveness of such an intervention in a variety of contexts, languages and cultures leading to the overall goal of delivering an evidence-based intervention for mental health in the workplace. Please refer to Item 2a and registration ISRCTN14104664. Registered on 12th July 2022.
Sections du résumé
BACKGROUND
BACKGROUND
Well-organised and managed workplaces can be a source of wellbeing. The construction, healthcare and information and communication technology sectors are characterised by work-related stressors (e.g. high workloads, tight deadlines) which are associated with poorer mental health and wellbeing. The MENTUPP intervention is a flexibly delivered, multi-level approach to supporting small- and medium-sized enterprises (SMEs) in creating mentally healthy workplaces. The online intervention is tailored to each sector and designed to support employees and leaders dealing with mental health difficulties (e.g. stress), clinical level anxiety and depression, and combatting mental health-related stigma. This paper presents the protocol for the cluster randomised controlled trial (cRCT) of the MENTUPP intervention in eight European countries and Australia.
METHODS
METHODS
Each intervention country will aim to recruit at least two SMEs in each of the three sectors. The design of the cRCT is based on the experiences of a pilot study and guided by a Theory of Change process that describes how the intervention is assumed to work. SMEs will be randomly assigned to the intervention or control conditions. The aim of the cRCT is to assess whether the MENTUPP intervention is effective in improving mental health and wellbeing (primary outcome) and reducing stigma, depression and suicidal behaviour (secondary outcome) in employees. The study will also involve a process and economic evaluation.
CONCLUSIONS
CONCLUSIONS
At present, there is no known multi-level, tailored, flexible and accessible workplace-based intervention for the prevention of non-clinical and clinical symptoms of depression, anxiety and burnout, and the promotion of mental wellbeing. The results of this study will provide a comprehensive overview of the implementation and effectiveness of such an intervention in a variety of contexts, languages and cultures leading to the overall goal of delivering an evidence-based intervention for mental health in the workplace.
TRIAL REGISTRATION
BACKGROUND
Please refer to Item 2a and registration ISRCTN14104664. Registered on 12th July 2022.
Identifiants
pubmed: 37777787
doi: 10.1186/s13063-023-07537-0
pii: 10.1186/s13063-023-07537-0
pmc: PMC10543326
doi:
Types de publication
Clinical Trial Protocol
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
621Subventions
Organisme : European Commission
ID : 848137
Investigateurs
Ainslie O'Connor
(A)
Ana Moreno-Alcázar
(A)
Andia Meksi
(A)
Andras Szekely
(A)
Anthony LaMontagne
(A)
Ariel Como
(A)
Arilda Dushaj
(A)
Asmae Doukani
(A)
Azucena Justicia
(A)
Bridget Hogg
(B)
Carolyn Holland
(C)
Charlotte Paterson
(C)
Chris Lockwood
(C)
Daniel Guinart
(D)
Doireann Ní Dhálaigh
(DN)
Dooyoung Kim
(D)
Eileen Williamson
(E)
Eva Zsak
(E)
Genc Burazeri
(G)
Grace Cully
(G)
Grace Davey
(G)
György Purebl
(G)
Ilinca Serbanescu
(I)
Jaap van Weeghel
(J)
Juan Carlos Medina Alcaraz
(JCM)
Joe Eustace
(J)
Juliane Hug
(J)
Kairi Kõlves
(K)
Karen Mulcahy
(K)
Katherine Thomson
(K)
Kristian Wahlbeck
(K)
Lars de Winter
(L)
Laura Cox
(L)
Marta Fontana
(M)
Peter Trembeczky
(P)
Pia Driessen
(P)
Rebecca Lohmann-Devantier
(R)
Reiner Rugulies
(R)
Ruth Benson
(R)
Saara Rapeli
(S)
Sarah Ihinonvien
(S)
Sevim Mustafa
(S)
Stefan Hackel
(S)
Susan Alexander
(S)
Tanya King
(T)
Ulrich Hegerl
(U)
Vanda Scott
(V)
Wendy Orchard
(W)
Informations de copyright
© 2023. BioMed Central Ltd., part of Springer Nature.
Références
Health Promot Int. 2019 Dec 1;34(6):1179-1190
pubmed: 30452649
Implement Sci. 2021 Jul 19;16(1):73
pubmed: 34281587
BMC Public Health. 2023 Jun 17;23(1):1171
pubmed: 37330460
Br J Psychiatry. 2015 Dec;207(6):507-14
pubmed: 26382952
Int J Environ Res Public Health. 2021 Jan 29;18(3):
pubmed: 33572955
Am J Health Promot. 2007 Sep-Oct;22(1):45-53
pubmed: 17894263
Stress Health. 2016 Aug;32(3):201-15
pubmed: 25044861
Syst Rev. 2021 Jan 28;10(1):41
pubmed: 33509258
Psychol Med. 2017 Jun;47(8):1342-1356
pubmed: 28122650
Eval Rev. 2008 Oct;32(5):435-52
pubmed: 18477737
Med Care. 2013 Jan;51(1):99-107
pubmed: 23132203
Am J Public Health. 2008 Aug;98(8):1503-9
pubmed: 18048790
JAMA. 2007 Sep 26;298(12):1401-11
pubmed: 17895456
J Nurs Adm. 2011 Oct;41(10):428-33
pubmed: 21934430
Aust N Z J Psychiatry. 2018 Jan;52(1):15-23
pubmed: 28835112
Lancet Psychiatry. 2018 Apr;5(4):303
pubmed: 29580608
Trials. 2012 Aug 01;13:120
pubmed: 22853820
J Occup Environ Med. 2020 Jul;62(7):503-510
pubmed: 32730026
J Pharm Bioallied Sci. 2015 Apr;7(Suppl 1):S9-S13
pubmed: 26015763
Br J Psychiatry. 2004 Oct;185:342-9
pubmed: 15458995
Psychiatry Res. 2021 Jun;300:113913
pubmed: 33839422
Psychiatr Rehabil J. 2016 Sep;39(3):211-21
pubmed: 27618458
Eur J Work Organ Psychol. 2020 Aug 26;30(3):415-427
pubmed: 34518756
QJM. 2020 Oct 1;113(10):707-712
pubmed: 32539153
Psychosom Med. 2016 Jul-Aug;78(6):716-27
pubmed: 27187854
Int J Environ Res Public Health. 2020 Oct 27;17(21):
pubmed: 33120930
Drug Alcohol Rev. 2018 May;37(4):502-513
pubmed: 29349868
Oncol Nurs Forum. 2018 May 1;45(3):380-388
pubmed: 29683121
Lancet Psychiatry. 2014 Nov;1(6):467-82
pubmed: 26361202
Occup Environ Med. 2017 Mar;74(4):301-310
pubmed: 28108676
Scand J Work Environ Health. 2009 Jan;35(1):7-18
pubmed: 19065280
Saf Health Work. 2019 Dec;10(4):482-503
pubmed: 31890332
Am J Epidemiol. 2008 May 15;167(10):1143-51
pubmed: 18413361
Value Health. 2015 Sep;18(6):753-8
pubmed: 26409601
Int J Environ Res Public Health. 2022 Jan 15;19(2):
pubmed: 35055773
BMJ. 2015 Mar 19;350:h1258
pubmed: 25791983
Soc Sci Med. 2010 Feb;70(3):342-350
pubmed: 19896256
J Adv Nurs. 2021 Feb;77(2):1013-1016
pubmed: 33617038
Int J Environ Res Public Health. 2019 Jun 13;16(12):
pubmed: 31200573
PLoS One. 2022 Nov 16;17(11):e0277114
pubmed: 36383613
J Med Internet Res. 2017 Jun 15;19(6):e213
pubmed: 28619701
Scand J Work Environ Health. 2018 Nov 1;44(6):613-621
pubmed: 30033477
BMC Med. 2014 May 09;12:74
pubmed: 24886246
J Affect Disord. 2021 Jul 1;290:378-386
pubmed: 34082284
Mayo Clin Proc Innov Qual Outcomes. 2019 Sep 26;3(4):384-408
pubmed: 31993558
Int J Environ Res Public Health. 2011 Nov;8(11):4180-96
pubmed: 22163201
Curr Opin Psychiatry. 2017 Sep;30(5):339-345
pubmed: 28661906
Int J Environ Res Public Health. 2020 Dec 18;17(24):
pubmed: 33352940
J Occup Health Psychol. 2019 Feb;24(1):127-138
pubmed: 29723001
Eur Arch Psychiatry Clin Neurosci. 2023 Apr;273(3):739-753
pubmed: 35867155
JAMA Psychiatry. 2021 Apr 1;78(4):361-371
pubmed: 33471111
BMJ. 2013 Jan 08;346:e7586
pubmed: 23303884
JMIR Ment Health. 2016 May 11;3(2):e13
pubmed: 27170553
J Constr Eng Manag. 2020 Mar;146(3):
pubmed: 33408438
Int J Environ Res Public Health. 2019 Aug 19;16(16):
pubmed: 31430939
BMJ. 2021 Sep 30;374:n2061
pubmed: 34593508
Healthcare (Basel). 2021 Jun 14;9(6):
pubmed: 34198556
Ann Work Expo Health. 2018 Sep 13;62(suppl_1):S93-S100
pubmed: 30212883
Scand J Work Environ Health. 2017 Jul 1;43(4):294-306
pubmed: 28306759
J Holist Nurs. 2016 Mar;34(1):80-90
pubmed: 25846550
Work. 2009;33(1):81-116
pubmed: 19597288
J Gen Intern Med. 2015 Aug;30(8):1105-11
pubmed: 25724571
BMC Public Health. 2015 Aug 01;15:738
pubmed: 26232123
Can J Psychiatry. 2019 Jun;64(1_suppl):39S-47S
pubmed: 31122049
Adm Policy Ment Health. 2011 Mar;38(2):65-76
pubmed: 20957426
Front Public Health. 2019 Mar 29;7:64
pubmed: 30984733
Scand J Work Environ Health. 2018 May 1;44(3):239-250
pubmed: 29423526
Am J Crit Care. 2018 Nov;27(6):508-512
pubmed: 30385543
Patient Educ Couns. 2010 Feb;78(2):184-90
pubmed: 19467822
Int Arch Occup Environ Health. 2023 Oct;96(8):1149-1165
pubmed: 37452149
J Ment Health. 2021 Feb;30(1):1-2
pubmed: 32339041
J Affect Disord. 2020 Nov 1;276:53-61
pubmed: 32697716
Psychiatr Rehabil J. 2017 Jun;40(2):252-259
pubmed: 27786520
Int J Qual Stud Health Well-being. 2013 Feb 18;8:
pubmed: 23422265
BMC Psychiatry. 2014 May 09;14:131
pubmed: 24884425